Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126099011 | 12609901 | 1 | I | 2016 | 20160725 | 20160801 | 20160801 | EXP | US-AMGEN-USASP2016096850 | AMGEN | 66.00 | YR | E | F | Y | 0.00000 | 20160801 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126099011 | 12609901 | 1 | PS | SENSIPAR | CINACALCET HYDROCHLORIDE | 1 | Oral | 30 MG, QD | 21688 | 30 | MG | TABLET | QD | ||||||
| 126099011 | 12609901 | 2 | C | INSULIN | INSULIN NOS | 1 | UNK UNK, BID | 0 | BID | ||||||||||
| 126099011 | 12609901 | 3 | C | AMARYL | GLIMEPIRIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126099011 | 12609901 | 1 | Osteoporosis |
| 126099011 | 12609901 | 2 | Diabetes mellitus |
| 126099011 | 12609901 | 3 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126099011 | 12609901 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126099011 | 12609901 | Drug dose omission | |
| 126099011 | 12609901 | Escherichia infection | |
| 126099011 | 12609901 | Off label use | |
| 126099011 | 12609901 | Pharyngeal disorder | |
| 126099011 | 12609901 | Thyroid operation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |